Kellaris, Georgios
Khan, Kamal
Baig, Shahid M.
Tsai, I-Chun
Zamora, Francisca Millan
Ruggieri, Paul
Natowicz, Marvin R.
Katsanis, Nicholas http://orcid.org/0000-0002-2480-0171
Article History
Received: 30 November 2017
Accepted: 15 February 2018
First Online: 1 March 2018
Ethics approval and consent to participate
: The study was approved by Cleveland Clinic Institutional Review Board protocol #06-333 review board, and the family was enrolled in the study under informed consent, including consent to publish the study’s findings. All experiments involving the use of zebrafish (Danio rerio) were approved by the Duke University Institutional Animal Care and Use Committee (IACUC).
: Written informed consent for publication of clinical details and clinical images was obtained from the parent of the probands.
: NK is a paid consultant and holds founding stock in Rescindo Therapeutics.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.